Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Novel biomarkers for primary biliary cholangitis to improve diagnosis and understand underlying regulatory mechanisms.

Bombaci M, Pesce E, Torri A, Carpi D, Crosti M, Lanzafame M, Cordiglieri C, Sinisi A, Moro M, Bernuzzi F, Gerussi A, Geginat J, Muratori L, Terracciano LM, Invernizzi P, Abrignani S, Grifantini R.

Liver Int. 2019 Apr 29. doi: 10.1111/liv.14128. [Epub ahead of print]

PMID:
31033124
2.

Magnetically driven drug delivery systems improving targeted immunotherapy for colon-rectal cancer.

Grifantini R, Taranta M, Gherardini L, Naldi I, Parri M, Grandi A, Giannetti A, Tombelli S, Lucarini G, Ricotti L, Campagnoli S, De Camilli E, Pelosi G, Baldini F, Menciassi A, Viale G, Pileri P, Cinti C.

J Control Release. 2018 Jun 28;280:76-86. doi: 10.1016/j.jconrel.2018.04.052. Epub 2018 May 4.

PMID:
29733876
3.

Enhancing Antibody Serodiagnosis Using a Controlled Peptide Coimmobilization Strategy.

Sola L, Gagni P, D'Annessa I, Capelli R, Bertino C, Romanato A, Damin F, Bergamaschi G, Marchisio E, Cuzzocrea A, Bombaci M, Grifantini R, Chiari M, Colombo G, Gori A, Cretich M.

ACS Infect Dis. 2018 Jun 8;4(6):998-1006. doi: 10.1021/acsinfecdis.8b00014. Epub 2018 Mar 29.

PMID:
29570266
4.

TCTN2: a novel tumor marker with oncogenic properties.

Cano-Rodriguez D, Campagnoli S, Grandi A, Parri M, Camilli E, Song C, Jin B, Lacombe A, Pierleoni A, Bombaci M, Cordiglieri C, Ruiters MH, Viale G, Terracciano L, Sarmientos P, Abrignani S, Grandi G, Pileri P, Rots MG, Grifantini R.

Oncotarget. 2017 Aug 24;8(56):95256-95269. doi: 10.18632/oncotarget.20438. eCollection 2017 Nov 10.

5.

CombiROC: an interactive web tool for selecting accurate marker combinations of omics data.

Mazzara S, Rossi RL, Grifantini R, Donizetti S, Abrignani S, Bombaci M.

Sci Rep. 2017 Mar 30;7:45477. doi: 10.1038/srep45477.

6.

Corrigendum to "Multifunctional all-in-one drug delivery systems for tumor targeting and sequential release of three different anti-tumor drugs" [Biomaterials 76C (2015) 399-407].

Fan L, Zhang Y, Wang F, Yang Q, Tan J, Grifantini R, Wu H, Song C, Jin B.

Biomaterials. 2017 Apr;122:201. doi: 10.1016/j.biomaterials.2016.11.002. Epub 2016 Dec 18. No abstract available.

PMID:
28003046
7.

ERMP1, a novel potential oncogene involved in UPR and oxidative stress defense, is highly expressed in human cancer.

Grandi A, Santi A, Campagnoli S, Parri M, De Camilli E, Song C, Jin B, Lacombe A, Castori-Eppenberger S, Sarmientos P, Grandi G, Viale G, Terracciano L, Chiarugi P, Pileri P, Grifantini R.

Oncotarget. 2016 Sep 27;7(39):63596-63610. doi: 10.18632/oncotarget.11550.

8.

FAT1: a potential target for monoclonal antibody therapy in colon cancer.

Pileri P, Campagnoli S, Grandi A, Parri M, De Camilli E, Song C, Ganfini L, Lacombe A, Naldi I, Sarmientos P, Cinti C, Jin B, Grandi G, Viale G, Terracciano L, Grifantini R.

Br J Cancer. 2016 Jun 28;115(1):40-51. doi: 10.1038/bjc.2016.145. Epub 2016 Jun 21.

9.

Supporting Data for Multifunctional all-in-one drug delivery systems for tumor targeting and sequential release of three different anti-tumor drugs.

Wu G, Song C, Grifantini R, Fan L, Wu H, Jin B.

Data Brief. 2016 Feb 15;7:148-51. doi: 10.1016/j.dib.2016.02.026. eCollection 2016 Jun.

10.

Multifunctional all-in-one drug delivery systems for tumor targeting and sequential release of three different anti-tumor drugs.

Fan L, Zhang Y, Wang F, Yang Q, Tan J, Grifantini R, Wu H, Song C, Jin B.

Biomaterials. 2016 Jan;76:399-407. doi: 10.1016/j.biomaterials.2015.10.069. Epub 2015 Oct 27. Erratum in: Biomaterials. 2017 Apr;122:201.

PMID:
26561936
11.

Negatively charged AuNP modified with monoclonal antibody against novel tumor antigen FAT1 for tumor targeting.

Fan L, Campagnoli S, Wu H, Grandi A, Parri M, De Camilli E, Grandi G, Viale G, Pileri P, Grifantini R, Song C, Jin B.

J Exp Clin Cancer Res. 2015 Sep 15;34:103. doi: 10.1186/s13046-015-0214-x.

12.

Angiopoietin-like 7, a novel pro-angiogenetic factor over-expressed in cancer.

Parri M, Pietrovito L, Grandi A, Campagnoli S, De Camilli E, Bianchini F, Marchiò S, Bussolino F, Jin B, Sarmientos P, Grandi G, Viale G, Pileri P, Chiarugi P, Grifantini R.

Angiogenesis. 2014 Oct;17(4):881-96. doi: 10.1007/s10456-014-9435-4. Epub 2014 Jun 6.

PMID:
24903490
13.

Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro.

Bartolini E, Ianni E, Frigimelica E, Petracca R, Galli G, Berlanda Scorza F, Norais N, Laera D, Giusti F, Pierleoni A, Donati M, Cevenini R, Finco O, Grandi G, Grifantini R.

J Extracell Vesicles. 2013 May 6;2. doi: 10.3402/jev.v2i0.20181. eCollection 2013.

14.

Adaptive response of Group B streptococcus to high glucose conditions: new insights on the CovRS regulation network.

Di Palo B, Rippa V, Santi I, Brettoni C, Muzzi A, Metruccio MM, Grifantini R, Telford JL, Paccani SR, Soriani M.

PLoS One. 2013 Apr 9;8(4):e61294. doi: 10.1371/journal.pone.0061294. Print 2013.

15.

EphA2-mediated mesenchymal-amoeboid transition induced by endothelial progenitor cells enhances metastatic spread due to cancer-associated fibroblasts.

Giannoni E, Taddei ML, Parri M, Bianchini F, Santosuosso M, Grifantini R, Fibbi G, Mazzanti B, Calorini L, Chiarugi P.

J Mol Med (Berl). 2013 Jan;91(1):103-15. doi: 10.1007/s00109-012-0941-9. Epub 2012 Aug 19.

PMID:
22903544
16.

Multi high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus case.

Bensi G, Mora M, Tuscano G, Biagini M, Chiarot E, Bombaci M, Capo S, Falugi F, Manetti AG, Donato P, Swennen E, Gallotta M, Garibaldi M, Pinto V, Chiappini N, Musser JM, Janulczyk R, Mariani M, Scarselli M, Telford JL, Grifantini R, Norais N, Margarit I, Grandi G.

Mol Cell Proteomics. 2012 Jun;11(6):M111.015693. doi: 10.1074/mcp.M111.015693. Epub 2012 Jan 27.

17.

Surface interactome in Streptococcus pyogenes.

Galeotti CL, Bove E, Pezzicoli A, Nogarotto R, Norais N, Pileri S, Lelli B, Falugi F, Balloni S, Tedde V, Chiarot E, Bombaci M, Soriani M, Bracci L, Grandi G, Grifantini R.

Mol Cell Proteomics. 2012 Apr;11(4):M111.015206. doi: 10.1074/mcp.M111.015206. Epub 2011 Dec 22.

18.

Peroxide stimulon and role of PerR in group A Streptococcus.

Grifantini R, Toukoki C, Colaprico A, Gryllos I.

J Bacteriol. 2011 Dec;193(23):6539-51. doi: 10.1128/JB.05924-11. Epub 2011 Sep 23.

19.

A novel polyclonal antibody library for expression profiling of poorly characterized, membrane and secreted human proteins.

Grifantini R, Pagani M, Pierleoni A, Grandi A, Parri M, Campagnoli S, Pileri P, Cattaneo D, Canidio E, Pontillo A, De Camilli E, Bresciani A, Marinoni F, Pedrazzoli E, Nogarotto R, Abrignani S, Viale G, Sarmientos P, Grandi G.

J Proteomics. 2011 Dec 21;75(2):532-47. doi: 10.1016/j.jprot.2011.08.018. Epub 2011 Sep 5.

PMID:
21920474
20.

Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines.

Finco O, Frigimelica E, Buricchi F, Petracca R, Galli G, Faenzi E, Meoni E, Bonci A, Agnusdei M, Nardelli F, Bartolini E, Scarselli M, Caproni E, Laera D, Zedda L, Skibinski D, Giovinazzi S, Bastone R, Ianni E, Cevenini R, Grandi G, Grifantini R.

Proc Natl Acad Sci U S A. 2011 Jun 14;108(24):9969-74. doi: 10.1073/pnas.1101756108. Epub 2011 May 31.

21.

Exploiting antigenic diversity for vaccine design: the chlamydia ArtJ paradigm.

Soriani M, Petit P, Grifantini R, Petracca R, Gancitano G, Frigimelica E, Nardelli F, Garcia C, Spinelli S, Scarabelli G, Fiorucci S, Affentranger R, Ferrer-Navarro M, Zacharias M, Colombo G, Vuillard L, Daura X, Grandi G.

J Biol Chem. 2010 Sep 24;285(39):30126-38. doi: 10.1074/jbc.M110.118513. Epub 2010 Jun 30.

22.

Protein array profiling of tic patient sera reveals a broad range and enhanced immune response against Group A Streptococcus antigens.

Bombaci M, Grifantini R, Mora M, Reguzzi V, Petracca R, Meoni E, Balloni S, Zingaretti C, Falugi F, Manetti AG, Margarit I, Musser JM, Cardona F, Orefici G, Grandi G, Bensi G.

PLoS One. 2009 Jul 22;4(7):e6332. doi: 10.1371/journal.pone.0006332.

23.

CT043, a protective antigen that induces a CD4+ Th1 response during Chlamydia trachomatis infection in mice and humans.

Meoni E, Faenzi E, Frigimelica E, Zedda L, Skibinski D, Giovinazzi S, Bonci A, Petracca R, Bartolini E, Galli G, Agnusdei M, Nardelli F, Buricchi F, Norais N, Ferlenghi I, Donati M, Cevenini R, Finco O, Grandi G, Grifantini R.

Infect Immun. 2009 Sep;77(9):4168-76. doi: 10.1128/IAI.00344-09. Epub 2009 Jul 13.

24.

CsrRS regulates group B Streptococcus virulence gene expression in response to environmental pH: a new perspective on vaccine development.

Santi I, Grifantini R, Jiang SM, Brettoni C, Grandi G, Wessels MR, Soriani M.

J Bacteriol. 2009 Sep;191(17):5387-97. doi: 10.1128/JB.00370-09. Epub 2009 Jun 19.

25.

Capturing host-pathogen interactions by protein microarrays: identification of novel streptococcal proteins binding to human fibronectin, fibrinogen, and C4BP.

Margarit I, Bonacci S, Pietrocola G, Rindi S, Ghezzo C, Bombaci M, Nardi-Dei V, Grifantini R, Speziale P, Grandi G.

FASEB J. 2009 Sep;23(9):3100-12. doi: 10.1096/fj.09-131458. Epub 2009 May 5.

PMID:
19417080
26.

PerR confers phagocytic killing resistance and allows pharyngeal colonization by group A Streptococcus.

Gryllos I, Grifantini R, Colaprico A, Cary ME, Hakansson A, Carey DW, Suarez-Chavez M, Kalish LA, Mitchell PD, White GL, Wessels MR.

PLoS Pathog. 2008 Sep 5;4(9):e1000145. doi: 10.1371/journal.ppat.1000145.

27.

Identification of 2 hypothetical genes involved in Neisseria meningitidis cathelicidin resistance.

Frigimelica E, Bartolini E, Galli G, Grandi G, Grifantini R.

J Infect Dis. 2008 Apr 15;197(8):1124-32. doi: 10.1086/533456.

PMID:
18462162
28.

Mg(2+) signalling defines the group A streptococcal CsrRS (CovRS) regulon.

Gryllos I, Grifantini R, Colaprico A, Jiang S, Deforce E, Hakansson A, Telford JL, Grandi G, Wessels MR.

Mol Microbiol. 2007 Aug;65(3):671-83. Epub 2007 Jul 3.

29.

Comparative genomics of Neisseria meningitidis: core genome, islands of horizontal transfer and pathogen-specific genes.

Dunning Hotopp JC, Grifantini R, Kumar N, Tzeng YL, Fouts D, Frigimelica E, Draghi M, Giuliani MM, Rappuoli R, Stephens DS, Grandi G, Tettelin H.

Microbiology. 2006 Dec;152(Pt 12):3733-49.

PMID:
17159225
30.

Role of FNR and FNR-regulated, sugar fermentation genes in Neisseria meningitidis infection.

Bartolini E, Frigimelica E, Giovinazzi S, Galli G, Shaik Y, Genco C, Welsch JA, Granoff DM, Grandi G, Grifantini R.

Mol Microbiol. 2006 May;60(4):963-72.

31.

Effect of Neisseria meningitidis fur mutations on global control of gene transcription.

Delany I, Grifantini R, Bartolini E, Rappuoli R, Scarlato V.

J Bacteriol. 2006 Apr;188(7):2483-92.

32.

Characterization of a novel Neisseria meningitidis Fur and iron-regulated operon required for protection from oxidative stress: utility of DNA microarray in the assignment of the biological role of hypothetical genes.

Grifantini R, Frigimelica E, Delany I, Bartolini E, Giovinazzi S, Balloni S, Agarwal S, Galli G, Genco C, Grandi G.

Mol Microbiol. 2004 Nov;54(4):962-79.

33.

Identification of iron-activated and -repressed Fur-dependent genes by transcriptome analysis of Neisseria meningitidis group B.

Grifantini R, Sebastian S, Frigimelica E, Draghi M, Bartolini E, Muzzi A, Rappuoli R, Grandi G, Genco CA.

Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9542-7. Epub 2003 Jul 25.

34.

Gene expression profile in Neisseria meningitidis and Neisseria lactamica upon host-cell contact: from basic research to vaccine development.

Grifantini R, Bartolini E, Muzzi A, Draghi M, Frigimelica E, Berger J, Randazzo F, Grandi G.

Ann N Y Acad Sci. 2002 Dec;975:202-16.

PMID:
12538166
35.

Different profile of CD8+ effector T cells induced in Der p 1-allergic and naïve mice by DNA vaccination.

Draghi M, Jarman ER, Grifantini R, Galli-Stampino L, Lamb JR, Valiante NM, Grandi G.

Eur J Immunol. 2002 Dec;32(12):3720-8.

36.

Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays.

Grifantini R, Bartolini E, Muzzi A, Draghi M, Frigimelica E, Berger J, Ratti G, Petracca R, Galli G, Agnusdei M, Giuliani MM, Santini L, Brunelli B, Tettelin H, Rappuoli R, Randazzo F, Grandi G.

Nat Biotechnol. 2002 Sep;20(9):914-21. Epub 2002 Aug 12.

PMID:
12172557
37.

Combined automated PCR cloning, in vitro transcription/translation and two-dimensional electrophoresis for bacterial proteome analysis.

Norais N, Nogarotto R, Lacobini ET, Garaguso I, Grifantini R, Gauli G, Grandi G.

Proteomics. 2001 Nov;1(11):1378-89.

PMID:
11922598
38.

Emulsion/solvent evaporation as an alternative technique in pellet preparation.

Palmieri GF, Grifantini R, Di Martino P, Martelli S.

Drug Dev Ind Pharm. 2000 Nov;26(11):1151-8.

PMID:
11068688
39.

Multi-plasmid DNA vaccination avoids antigenic competition and enhances immunogenicity of a poorly immunogenic plasmid.

Grifantini R, Finco O, Bartolini E, Draghi M, Del Giudice G, Kocken C, Thomas A, Abrignani S, Grandi G.

Eur J Immunol. 1998 Apr;28(4):1225-32.

40.

Efficient conversion of 5-substituted hydantoins to D-alpha-amino acids using recombinant Escherichia coli strains.

Grifantini R, Galli G, Carpani G, Pratesi C, Frascotti G, Grandi G.

Microbiology. 1998 Apr;144 ( Pt 4):947-54.

PMID:
9579068
41.

Inhibitory activity of IL-1 receptor antagonist depends on the balance between binding capacity for IL-1 receptor type 1 and IL-1 receptor type II.

Ruggiero P, Bossù P, Macchia G, Del Grosso E, Sabbatini V, Bertini R, Colagrande A, Bizzarri C, Maurizi G, Di Cioccio V, D'Andrea G, Di Giulio A, Frigerio F, Grifantini R, Grandi G, Tagliabue A, Boraschi D.

J Immunol. 1997 Apr 15;158(8):3881-7.

PMID:
9103457
42.
43.

Mapping of receptor binding sites on IL-1 beta by reconstruction of IL-1ra-like domains.

Boraschi D, Bossù P, Ruggiero P, Tagliabue A, Bertini R, Macchia G, Gasbarro C, Pellegrini L, Melillo G, Ulisse E, Visconti U, Bizzarri C, Del Grosso E, Mackay AR, Frascotti G, Frigerio F, Grifantini R, Grandi G.

J Immunol. 1995 Nov 15;155(10):4719-25.

PMID:
7594472

Supplemental Content

Loading ...
Support Center